stockrow
Saturday 7 November 2026
Export SPTX’s income statement to Excel — free account
Seaport Therapeutics, Inc
SPTX Healthcare Biotechnology
- EPS
- +94.8%
- Free cash flow
- −43.8%
Quarter to September 2026, against a year earlier
21.18
0.79
+3.87%
Follow SPTX
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
|
+4 more TTM periods Free account |
0.00% | 0.00% | 0.00% | (74.36%) | |
| 0.00% | (32.08%) | (60.99%) | (37.78%) | ||
ROIC |
(324.62%) | (227.41%) | (61.12%) | (88.12%) | |
Return on Tangible Assets |
(35.51%) | (49.95%) | (50.47%) | (49.08%) | |
Free Cash Flow per Share |
(32.98) | (31.71) | (2.52) | (1.79) | |
Free Cash Flow |
(78.30) | (77.91) | (88.72) | (95.64) | |
Capital Expenditures |
(0.36) | — | — | — | |
| Other line items | |||||
Cash ROIC |
(17.45%) | (19.86%) | (12.75%) | (13.90%) | |
Accounts Payable Turnover |
— | — | — | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.01 | 0.01 | 0.01 | 0.01 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
— | 0.00% | 0.00% | 0.00% | |
Operating CF/Net income |
1.04 | 0.89 | 0.66 | 0.69 | |
Depreciation/Fixed assets |
(4.91) | (3.55) | (1.52) | (0.51) | |
Capex/Depreciation |
0.18 | 0.00 | 0.00 | 0.00 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(32.83) | (31.71) | (2.52) | (1.79) | |
Capex per Share |
(0.15) | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.00 | — | — | — |
Columns are period end dates · fundamentals updated 5 Nov 2026